Cause-specific death assessment of patients with stage I small-cell lung cancer: a competing risk analysis
Future oncology (London, England), 2019.
SCLCSEERcancer-specific deathcompeting risk nomogram
Stage I small-cell lung cancer (SCLC) is a potentially curable disease that needs timely and multidisciplinary management. The aim of this study was to evaluate the probability of cause-specific mortality for patients with stage I SCLC. We identified patients in the SEER database and constructed a proportional subdistribution hazard mod...More
Full Text (Upload PDF)
PPT (Upload PPT)